Is Tilt Testing Really Useful for Selecting Vasovagal Therapy?

  • A. Moya
  • T. Rius
  • J. Sagristá
  • G. Permanyer-Miralda


Head-up tilt test (HUT) was first described as a diagnostic tool for vasovagal syncope (VVS) in 1986 by Kenny et al. [1]. Since then, interest surrounding the test has increased dramatically, and it has been extended not only for diagnostic purposes but also in the management of patients with VVS. Most patients with VVS do not need to be treated, but in selected patients, with recurrent and severe episodes, treatment can be warranted.


Vasovagal Syncope Syncopic Episode Unexplained Syncope Vasovagal Reaction Organic Heart Disease 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Kenny RA, Bayliss J, Ingram A, Sutton R (1986) Head-up tilt test: a useful test for investigating unexplained syncope. Lancet 1: 1352–1354PubMedCrossRefGoogle Scholar
  2. 2.
    Fitzpatrick A, Theodorakis G, Vardas P et al (1991) The incidence of malignant vaso-vagal syndrome in patients with recurrent syncope. Eur Heart J 12: 389–394PubMedGoogle Scholar
  3. 3.
    Almquist A, Goldenberg IF, Milstein S et al (1989) Provocation of bradycardia and hypotension by isoproterenol and upright posture in patients with unexplained syncope. N Eng J Med 320: 346–351CrossRefGoogle Scholar
  4. 4.
    Strasbreg B, Rechavia E, Sagie A et al (1989) The head-up tilt table test in patients with syncope of unknown origin. Am Heart J 118: 923–927CrossRefGoogle Scholar
  5. 5.
    Grubb BP, Temesy-Armos P, Hahn H, Elliot L (1991) Utility of upright tilt table test in the evaluation and management of syncope of unknown origin. Am J Med 90: 6–10PubMedCrossRefGoogle Scholar
  6. 6.
    Moya A, Permanyer Miralda G, Sagristâ J, Mont L, Rius T, Soler Soler J (1993) Anâlisis de las respuestas a la prueba en tabla basculante en función de las características clínicas de los episodios sincopales en pacientes sin cardiopatia aparente. Rev Esp Cardiol 46: 214–219Google Scholar
  7. 7.
    Natale A, Akhtar M, Jayazery M et al (1995) Provocation of hypotension during head-up tilt testing in subjects with no history of syncope or presyncope. Circulation 92: 54–58PubMedCrossRefGoogle Scholar
  8. 8.
    Kapoor WN, Brabt N (1992) Evaluation of syncope by upright tilt testing with isoproterenol. A nonspecific test. Ann Intern Med 116: 358–363PubMedCrossRefGoogle Scholar
  9. 9.
    Raviele A, Menozi C, Brignole M et al (1995) Value of head-up tilt testing potentiated with sublingual nitroglycerin to assess the origin of unexplained syncope. Am J Cardiol 76: 267–272PubMedCrossRefGoogle Scholar
  10. 10.
    Morillo CA, Klein GJ, Zandri S, Yea R (1995) Diagnostic accuracy of a low-dose isoproterenol head up tilt protocol. Am Heart J 129: 901–908PubMedCrossRefGoogle Scholar
  11. 11.
    Kapoor WN, Smith M, Miller NL (1994) Upright tilt testing in evaluating syncope: a comprehensive literature review. Am J Med 97: 78–88PubMedCrossRefGoogle Scholar
  12. 12.
    Benditt DG, Ferguson DW, Grubb BP et al (1996) Tilt table testing for assessing syncope. ACC expert consensus document. J Am Coll Cardiol 28: 263–275PubMedCrossRefGoogle Scholar
  13. 13.
    Kapoor WN, Karpf M, Wieand S et al (1983) A prospective evaluation and follow-up of patients with syncope. N Eng J Med 309: 197–204CrossRefGoogle Scholar
  14. 14.
    Kapoor WN (1990) Evaluation and outcome of patients with syncope. Medicine 69: 160–175PubMedCrossRefGoogle Scholar
  15. 15.
    Teichman SL, Felder SD, Matos JA, Kim SG, Waspe LE, Fisher JD (1985) The value of electrophysiologic studies in syncope of undetermined origin: report of 150 cases. Am Heart J 110: 469–479PubMedCrossRefGoogle Scholar
  16. 16.
    Doherty JU, Pembrok-Rogers D, Grogan EW et al (1985) Electrophysiologic evaluation and follow-up characteristics of patients with recurrent unexplained syncope and presyncope. Am J Cardiol 55: 703–708PubMedCrossRefGoogle Scholar
  17. 17.
    Fitzpatrick A, Theodorakis G, Vardas P, Sutton R (1991) Methodology of head-up tilt testing in patients with unexplained syncope. J Am Coll Cardiol 17: 125–130PubMedCrossRefGoogle Scholar
  18. 18.
    Moya A, Romero B, Sagristâ J et al (1996) Sincope de origen desconocido: Rendimiento de un protocolo de estudio en seiscientos pacientes. Rev Esp Cardiol 49 [Suppl3]: 31 (abstr)Google Scholar
  19. 19.
    Rius T, Sagrista J, Mont L et al (1996) Utilidad clinica de la prueba en tabla basculante en pacientes con síncope y trastorno de la conducción intraventricular. Rev Esp Cardiol 49 [Suppl 3]: 33 (abstr)Google Scholar
  20. 20.
    Brignole M, Gianfranchi L, Menozzi C et al (1993) Role of autonomic reflexes in syncope associated with paroxysmal atrial fibrillation. J Am Coll Cardiol 22: 1123–1129PubMedCrossRefGoogle Scholar
  21. 21.
    Leitch JW, Klein GJ, Yee R, Leather RA, Kim YH (1992) Syncope associated with supraventricular tachycardia. An expression of tachycardia rate or vasomotor response?. Circulation 85: 1064–1071PubMedCrossRefGoogle Scholar
  22. 22.
    Alboni P, Menozzi C, Brignole M et al (1993) An abnormal neural reflex plays a role in causing syncope in sinus bradycardia. J Am Coll Cardiol 22: 1130–1134PubMedCrossRefGoogle Scholar
  23. 23.
    Sutton R, Petersen M, Brignole M, Raviele A, Menozzi C, Giani P (1992) Proposed classification for tilt induced vasovagal syncope. Eur J Cardiac Pacing Electrophysiol 3: 180–183Google Scholar
  24. 24.
    Sagristâ J, Permanyer-Miralda G, Moya A, Romero B, Rius T, Soler Soler J (1996) Reproducibility of head-up tilt test in patients with recent syncope, normal ECG and no organic heart disease. PACE 19: 640 (abstr)Google Scholar
  25. 25.
    Sheldon R, Splawinski J, Killam S (1992) Reproducibility of upright tilt-table tests in patients with syncope. Am J Cardiol 69: 1300–1305PubMedCrossRefGoogle Scholar
  26. 26.
    Harvey MN, Finta B, Goyal R et al (1996) Comparison of cardioinhibitory responses during tilt table testing and spontaneous episodes of syncope or near syncope. PACE 19: 616 (abstr)Google Scholar
  27. 27.
    Sra S, Murphy VS, Jayazeri MR et al (1992) Use of intravenous esmolol to predict efficacy of oral beta-adrenergic blocker therapy in patients with neurocardiogenic syncope. J Am Coll Cardiol 19: 402–408PubMedCrossRefGoogle Scholar
  28. 28.
    Leor J, Rotstein Z, Vered Z, Kaplinsky E, Truman S, Eldar M (1994) Absence of tachycardia during tilt test predicts failure of beta-blocker therapy in patients with neurocardiogenic syncope. Am Heart J 127: 1539–1543PubMedCrossRefGoogle Scholar
  29. 29.
    Benditt DG, Petersen M, Lurie K, Grubb BP, Sutton R (1995) Cardiac pacing for prevention of recurrent vasovagal syncope. Ann Int Med 122: 204–209PubMedCrossRefGoogle Scholar
  30. 30.
    Sra JS, Jayazeri MR, Avitall B et al (1993) Comparison of cardiac pacing with drug therapy in the treatment of neurocardiogenic (vasovagal) syncope with bradycardia or asystole. N Eng J Med 328: 1085–1090CrossRefGoogle Scholar
  31. 31.
    R, Petersen MEV (1995) The clinical spectrum of neurocardiogenic syncope. J Cardiovasc Electrophysiol 6: 54–58Google Scholar
  32. 32.
    Sheldon R, Rose S, Flanagan P, Koshman ML, Killam S (1996) Risk factors for syncope recurrence after a positive tilt-table test in patients with syncope. Circulation 93: 973–981PubMedCrossRefGoogle Scholar
  33. 33.
    Moya A, Romero B, Sagristâ J, Permanyer G, Rius T, Mont L, Soler-Soler J (1996) Relación de la respuesta a la prueba en tabla basculante con las características clínicas y evolutivas de los pacientes con sincope vasovagal. Rev Esp Cardiol 49 [Suppl 3]: 31 (abstr)Google Scholar
  34. 34.
    Morillo CA, Leitch JW, Yee R, Klein GJ (1993) A placebo controlled trial of intravenous and oral disopyramide for prevention of neurally mediated syncope. J Am Coll Cardiol 22: 1843–1848PubMedCrossRefGoogle Scholar
  35. 35.
    Moya A, Permanyer-Miralda G, Sagristâ-Sauleda J et al (1995) Limitations of head-up tilt test for evaluating the efficacy of therapeutic interventions in patients with vaso-vagal syncope: results of a controlled study of etilefrine versus placebo. J Am Coll Cardiol 25: 65–69PubMedCrossRefGoogle Scholar
  36. 36.
    Sutton R (1996) Is there an effective pharmacological treatment in the prevention of vasovagal syncope?. Arch Mal Coeur 89 (I): 25–28PubMedGoogle Scholar
  37. 37.
    Brooks R, Ruskin JN, Powell AC, Newell J, Garan H, McGovern BA (1993) Prospective evaluation of day-to-day reproducibility of upright tilt-table testing in unexplained syncope. Am J Cardiol 71: 1289–1292PubMedCrossRefGoogle Scholar
  38. 38.
    Chen XC, Chen MY, Remole S et al (1993) Reproducibility of head up tilt-table testing for eliciting susceptibility to neurally mediated syncope in patients without structural heart disease. Am J Cardiol 71: 1289–1292CrossRefGoogle Scholar
  39. 39.
    Raviele A, Gasparini G, DiPede F, Delise P, Bonso A, Picolo E (1990) Usefulness of head-up tilt test in evaluating patients with syncope of unknown origin and negative electrophysiologic study. Am J Cardiol 65: 1322–1327PubMedCrossRefGoogle Scholar
  40. 40.
    Milsetin S, Buetikofer J, Dunningan A, Benditt DG, Gornik C, Reyes WJ (1990) Usefulness of disopyramide for prevention of upright tilt-induced hypotension and bradycardia. Am J Cardiol 65: 1330–1344Google Scholar
  41. 41.
    Muller G, Deal BD, Strasburger JF, Benson DW (1993) Usefulness of metoprolol for unexplained syncope and positive responses to tilt testing in young persons. Am J Cardiol 71: 592–595PubMedCrossRefGoogle Scholar
  42. 42.
    Grubb BP, Wolfe DA, Samoil D, Temesy-Armos P, Hahn H, Elliot L (1993) Usefulness of fluoxetine hydrocloride for prevention of resistant upright tilt induced syncope. PACE 16: 458–464PubMedCrossRefGoogle Scholar
  43. 43.
    Grubb BP, Samoil D, Kosinski D, Kip K, Brewster P (1994) Use of sertraline hydro-d oride in the treatment of refractory neurocardiogenic syncope in children and adolescents. J Am Coll Cardiol 24: 490–494PubMedCrossRefGoogle Scholar
  44. 44.
    Brignole M, Menozzi C, Gianfranchi L, Lolli G, Bottoni N, Oddone D (1992) A controlled trial of acute and long-term medical therapy for vasodepressor vasovagal syncope. Am J Cardiol 70: 339–342PubMedCrossRefGoogle Scholar
  45. 45.
    Dhala A, Natale A, Sra J et al (1995) Relevance of asystole during head-up tilt testing. Am J Cardiol 75: 251–254PubMedCrossRefGoogle Scholar
  46. 46.
    Mahanonda N, Bhuripanyo K, Kangkagate C et al (1995) Randomized double-blind, placebo-controlled trial of oral atenolol in patients with unexplained syncope and positive upright tilt table test results. Am Heart J 130: 1250–1253PubMedCrossRefGoogle Scholar
  47. 47.
    Jhamb DK, Singh B, Sharda B et al (1996) Comparative study of the efficacy of metoprolol and verapamil in patients with syncope and positive head-up tilt response. Am Heart J 132: 608–611PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag Italia 1998

Authors and Affiliations

  • A. Moya
    • 1
  • T. Rius
    • 1
  • J. Sagristá
    • 1
  • G. Permanyer-Miralda
    • 1
  1. 1.Unitat d’Arítmies, Servei de CardiologiaHospital Vall d’HebronBarcelonaSpain

Personalised recommendations